GERAS Frailty Rehabilitation at Home During COVID-19
4 de marzo de 2022 actualizado por: Alexandra Papaioannou, McMaster University
GERAS Frailty Rehabilitation at Home: Virtual Bundled Care for Seniors Who Are Frail to Build Strength and Resilience During COVID-19
The coronavirus disease 2019 (COVID-19) pandemic is keeping people apart, which can take a toll on physical and mental health.
Many healthcare professionals are concerned vulnerable seniors may become deconditioned, which substantially increases risk of health complications and need for hospitalization.
To address the immediate impact of COVID-19 policies (i.e., physical distancing, reduced access to care), the GERAS Frailty Rehabilitation model will be adapted to be delivered remotely in the homes of vulnerable seniors.
The investigators' aim is to understand how to best build resilience among vulnerable seniors in the community through at-home rehabilitation services (socialization, exercise, nutrition, and medication support).
Descripción general del estudio
Estado
Terminado
Condiciones
Descripción detallada
During this unprecedented time of COVID-19, many healthcare professionals are concerned that vulnerable seniors who are housebound and isolated will become deconditioned resulting in functional losses in mental status, continence and ability to complete activities of daily living. Total inactivity in seniors can result in a 10-20% decrease in muscle strength per week (1 -3% per day). Loss of muscle strength may quickly convert a vulnerable older adult who was ambulatory into a bedridden state. This will affect the health of seniors and increase demand on healthcare systems. An innovative model to deliver frailty rehabilitation services remotely is urgently needed to: 1) increase access to specialized services 2) provide added supports for seniors discharged from the hospital who are in need of rehabilitation and 3) build resilience in seniors to prevent re-hospitalization or institutionalization. Therefore, to address the immediate impact of COVID-19 policies (i.e., physical distancing and reduced access to care), the GERAS Frailty Rehabilitation model will be adapted to be delivered remotely in the homes of vulnerable seniors. This proof-of-concept, randomized control trial aims to understand how to best build resilience among vulnerable seniors through at-home rehabilitation services using socialization, exercise, nutrition, and medication support.
The short-term immediate goals for this RCT are to help vulnerable seniors who are isolated because of physical distancing measures to build strength and resilience throughout the COVID-19 pandemic. The major deliverables are 1) the adaptation of an in-person program to virtual delivery 2) the piloting of a care pathway with inter-disciplinary professionals that can be expanded to reach a larger number of individuals.
The long-term goal of the study is the seamless implementation of a new model for multimodal Frailty Rehabilitation that closes the care gap in rehabilitation for frail seniors in the immediate and foreseeable future.
Tipo de estudio
Intervencionista
Inscripción (Actual)
70
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Ubicaciones de estudio
-
-
Ontario
-
Hamilton, Ontario, Canadá, L8M1W9
- McMaster University - Hamilton Health Sciences (St. Peter's Site)
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
65 años y mayores (Adulto Mayor)
Acepta Voluntarios Saludables
No
Géneros elegibles para el estudio
Todos
Descripción
Inclusion Criteria:
- Community-dwelling adults aged ≥ 65 years of age;
- Score between 4-6 (inclusive) on the clinical frailty scale;
- Able to ambulate independently with or without a walking aid; OR with caregiver supervision at home;
- Obtain clearance for exercise: For hospital referrals - average resting heart rate between 50-100 bpm and average blood pressure less than or equal to 160/90mmHg (as per Canadian Society for Exercise Physiology guidelines for exercise clearance); OR Self- referrals: Obtain exercise clearance from their family physician prior to the first intervention session.
Exclusion Criteria:
- Unable to speak or understand English and has no caregiver for translation;
- Significant cognitive impairment where they may have difficulty following two-step commands;
- Receiving palliative/end of life care;
- Unstable angina or unstable heart failure;
- Travel plans that would result in missing greater than 20% of the trial's 12-week duration;
- Currently attending a group exercise program.
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Doble
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Comparador activo: Socialization
Participants randomized to the socialization arm will receive once-weekly phone calls from medical student volunteers for a total of 12-weeks (n=35).
This program pairs health professional student volunteers with older adults in the community to provide social comfort while heightened physical distancing measures are in place during the current COVID-19 pandemic.
Attendance and duration of the phone calls will be logged.
|
Social interaction is associated with better mental and physical health, and evidence suggests that group versus individual engagement may offer unique cognitive benefits for older adults as well as peer reinforcement and encouragement.
|
|
Experimental: Multi-Modal Frailty Rehabilitation
Multi-modal frailty rehabilitation will involve virtual care including 1x/week socialization, 2x/week exercise (small group physiotherapy live-streamed sessions), nutrition (virtual consult), and medication support (virtual pharmacist consult) all through a videoconferencing system.
|
Social interaction is associated with better mental and physical health, and evidence suggests that group versus individual engagement may offer unique cognitive benefits for older adults as well as peer reinforcement and encouragement.
Participants will receive twice-weekly (one hour per class) virtual exercise via small-group physiotherapy sessions for a total of 12 weeks.
All exercise sessions will occur virtually via a videoconferencing system.
The classes will focus on functional movements specifically designed for seniors with frailty and mobility challenges, and will include modifications for gait aids such as canes or walkers.
Class sizes will be small to allow for tailoring of exercises based on challenging, safe, progressive, evidence-based exercises.
In accordance with recent guidelines to achieve 3 hours/week for fall prevention practice in older adults, participants will also be provided with tailored supplemental home exercises developed by the study physiotherapist to gain an additional 1 hour of physical activity.
Nutrition Consult: Participants will be scheduled for a one-on-one virtual nutrition consult. During the consultation, study staff will assess the nutritional status of the participant and will provide them with counselling and coaching to improve their nutrition. Protein Supplementation: Oral nutrition supplements commercially available from Nestle will be provided unless contraindicated. The oral nutrition supplement contains 360 calories and 14 grams of protein per serving. Participants are advised to take this with a meal or within 3 hours of exercise on activity days.
A study pharmacist will review the participant's medication list and will utilize Beers and/or START/STOPP criteria to provide recommendations to optimize/update their medications to the participant's healthcare provider.
Study geriatricians will be listed as contacts on the primary care provider recommendations and available for consultation.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Physical Function
Periodo de tiempo: Baseline and 12 Weeks Post-Intervention
|
Assessed by the 5x Sit-to-Stand (time to complete).
Faster times to complete indicate better performance.
|
Baseline and 12 Weeks Post-Intervention
|
|
Change in Mental Health
Periodo de tiempo: Baseline and 12 Weeks Post-Intervention
|
Assessed by the Depression Anxiety Stress Scale (DASS-21).
Higher scores indicate greater risk of depression, anxiety and stress [depression, anxiety, stress subscores range 0-21].
|
Baseline and 12 Weeks Post-Intervention
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Sarcopenia
Periodo de tiempo: Baseline and 12 Weeks Post-Intervention
|
Assessed by the SARC-F - Self-reported strength, assistance with walking, rising from a chair, climbing stairs and falls.
Higher scores indicate greater level of sarcopenia [range 0-10].
|
Baseline and 12 Weeks Post-Intervention
|
|
Change in Frailty
Periodo de tiempo: Baseline and 12 Weeks Post-Intervention
|
Assessed by the Fit-Frailty Index.
Higher scores indicate greater degree of frailty [range 0-1].
|
Baseline and 12 Weeks Post-Intervention
|
|
Change in Self-Efficacy
Periodo de tiempo: Baseline and 12 Weeks Post-Intervention
|
Balance confidence will be assessed using the Activities-specific Balance Confidence Scale (ABCs).
Higher scores indicate greater balance confidence [range 0-100].
|
Baseline and 12 Weeks Post-Intervention
|
|
Self-Reported Change in Function, Health and Well-Being
Periodo de tiempo: Baseline and 12 Weeks Post-Intervention
|
Assessed by the interRAI Community Rehab Assessment - Self-Report
|
Baseline and 12 Weeks Post-Intervention
|
|
Clinician-Reported Change in Function, Health and Well-Being
Periodo de tiempo: Baseline and 12 Weeks Post-Intervention
|
Assessed by the interRAI Community Rehab Assessment - Clinician-Completed
|
Baseline and 12 Weeks Post-Intervention
|
|
Change in Fitness
Periodo de tiempo: Weekly up to 12 weeks
|
Assessed by the Borg Rate of Perceived Exertion after exercise.
Higher scores indicate greater level of exertion [range 6-20].
Also assessed using accelerometers (heart rate, sedentary time, physical activity time, energy expenditure).
|
Weekly up to 12 weeks
|
|
Program Satisfaction
Periodo de tiempo: 12 Weeks Post-Intervention
|
Assessed using a program questionnaire in accordance with the Kirkpatrick 5-Level Evaluation Model.
Scores will be on a 5-point Likert scale ranging from "Strongly Disagree" to "Strongly Agree".
|
12 Weeks Post-Intervention
|
|
Change in Health-Related Quality of Life
Periodo de tiempo: Baseline and 12 Weeks Post-Intervention
|
Assessed by the EQ-5D-5L scale.
Lower scores indicate better self-reported quality of life [range 0-100].
|
Baseline and 12 Weeks Post-Intervention
|
|
Change in Nutrition
Periodo de tiempo: Baseline and 12 Weeks Post-Intervention
|
Assessed by the Subjective Global Assessment.
Grades range from A-C where 'A' represents normal nutrition and 'C' represents severe malnourishment.
|
Baseline and 12 Weeks Post-Intervention
|
|
Change in Emergency Room Visits
Periodo de tiempo: Baseline and 12 Weeks Post-Intervention
|
Number of emergency room visits will be recorded.
Higher number of emergency room visits indicates higher healthcare utilization.
|
Baseline and 12 Weeks Post-Intervention
|
|
Change in Hospitalizations
Periodo de tiempo: Baseline and 12 Weeks Post-Intervention
|
Number of hospitalizations will be recorded.
Higher number of hospitalizations indicates higher healthcare utilization.
|
Baseline and 12 Weeks Post-Intervention
|
|
Change in Number of Calls to 911
Periodo de tiempo: Baseline and 12 Weeks Post-Intervention
|
Number of calls to 911 will be recorded.
Higher number of calls indicates higher healthcare utilization.
|
Baseline and 12 Weeks Post-Intervention
|
Otras medidas de resultado
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Feasibility Outcome #1 - Reach of intervention
Periodo de tiempo: 12 Weeks Post-Intervention
|
Assessed by the number of individuals who participated.
Target reach is 70 participants.
|
12 Weeks Post-Intervention
|
|
Feasibility Outcome #2 - Adoption of the Intervention
Periodo de tiempo: 12 Weeks Post-Intervention
|
Assessed by number of referral sites.
Target is 5 referral sites.
|
12 Weeks Post-Intervention
|
|
Feasibility Outcome #3 - Implementation of the Intervention
Periodo de tiempo: 12 Weeks Post-Intervention
|
Assessed by the number of individuals who completed the intervention.
Higher number of individuals completing the study indicates greater success in implementation.
|
12 Weeks Post-Intervention
|
|
Feasibility Outcome #4 - Maintenance of the Intervention
Periodo de tiempo: 12 Weeks Post-Intervention
|
Assessed by the number of referral sites continuing with a second cohort.
Greater number of referral sites continuing with a second cohort indicates greater maintenance.
|
12 Weeks Post-Intervention
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Investigadores
- Investigador principal: Alexandra Papaioannou, MD, MSc, Scientific Director, GERAS Centre for Aging Research
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Actual)
26 de agosto de 2020
Finalización primaria (Actual)
1 de noviembre de 2021
Finalización del estudio (Actual)
1 de noviembre de 2021
Fechas de registro del estudio
Enviado por primera vez
31 de julio de 2020
Primero enviado que cumplió con los criterios de control de calidad
4 de agosto de 2020
Publicado por primera vez (Actual)
5 de agosto de 2020
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
7 de marzo de 2022
Última actualización enviada que cumplió con los criterios de control de calidad
4 de marzo de 2022
Última verificación
1 de marzo de 2022
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
- Procesos Patológicos
- Infecciones por coronavirus
- Infecciones por coronaviridae
- Infecciones por Nidovirales
- Infecciones por virus de ARN
- Enfermedades virales
- Infecciones
- Infecciones del Tracto Respiratorio
- Enfermedades de las vías respiratorias
- Neumonía Viral
- Neumonía
- Enfermedades pulmonares
- COVID-19
- Fragilidad
Otros números de identificación del estudio
- 11408
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .